Form 13-F position report

UNITEDHEALTH GROUP INC

Reported by Ruane Cunniff & Goldfarb L P

UNH CUSIP 91324P102 Manager CIK 0001720792

Reported 710,287 shares, up 4,733 (0.7%) from the prior quarter.

Reported value -11.1%; share count 0.7% vs. the prior quarter.

Added
% of reported 13F value 4.24% This manager · Q3 2026
Shares 710,287 Quarter-end amount reported
Reported value $260,732,152 Fair value at quarter end
Consecutive quarters held 28 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 939350000
2022-03-31 928348000
2022-06-30 689032000
2022-09-30 666699000
2022-12-31 598902992
2023-03-31 521181231
2023-06-30 542464723
2023-09-30 552319473
2023-12-31 563017021
2024-03-31 508483826
2024-06-30 501023229
2024-09-30 564985054
2024-12-31 423908657
2025-03-31 430610490
2025-06-30 238170065
2025-09-30 261814402
2025-12-31 246261730
2026-03-31 197099650
2026-06-30 293249409
2026-09-30 260732152

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for UNITEDHEALTH GROUP INC held by Ruane Cunniff & Goldfarb L P.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 710,287 +4,733 (0.7%) 4.24% $260,732,152 2026-11-13
Q2 2026 Reduced 705,554 -22,853 (-3.1%) 4.56% $293,249,409 2026-08-14
Q1 2026 Reduced 728,407 -17,592 (-2.4%) 3.27% $197,099,650 2026-05-15
Q4 2025 Reduced 745,999 -12,224 (-1.6%) 3.85% $246,261,730 2026-02-13
Q3 2025 Reduced 758,223 -5,216 (-0.7%) 4.34% $261,814,402 2025-11-14
Q2 2025 Reduced 763,439 -58,729 (-7.1%) 4.08% $238,170,065 2025-08-14
Q1 2025 Reduced 822,168 -15,828 (-1.9%) 7.82% $430,610,490 2025-05-15
Q4 2024 Reduced 837,996 -128,319 (-13.3%) 7.2% $423,908,657 2025-02-14
Q3 2024 Reduced 966,315 -17,511 (-1.8%) 8.84% $564,985,054 2024-11-14
Q2 2024 Reduced 983,826 -44,037 (-4.3%) 7.81% $501,023,229 2024-08-14
Q1 2024 Reduced 1,027,863 -41,556 (-3.9%) 7.89% $508,483,826 2024-05-15
Q4 2023 Reduced 1,069,419 -26,040 (-2.4%) 9.0% $563,017,021 2024-02-14
Q3 2023 Reduced 1,095,459 -33,171 (-2.9%) 9.17% $552,319,473 2023-11-14
Q2 2023 Added 1,128,630 +25,811 (2.3%) 8.56% $542,464,723 2023-08-14
Q1 2023 Reduced 1,102,819 -26,803 (-2.4%) 8.52% $521,181,231 2023-05-15
Q4 2022 Reduced 1,129,622 -190,469 (-14.4%) 9.36% $598,902,992 2023-02-13
Q3 2022 Reduced 1,320,091 -21,404 (-1.6%) 9.9% $666,699,000 2022-11-14
Q2 2022 Reduced 1,341,495 -478,903 (-26.3%) 8.98% $689,032,000 2022-08-15
Q1 2022 Reduced 1,820,398 -50,296 (-2.7%) 9.14% $928,348,000 2022-05-13
Q4 2021 Reduced 1,870,694 -30,777 (-1.6%) 8.02% $939,350,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

3521 managers reported UNITEDHEALTH GROUP INC for Q3 2026.

Managers reporting UNITEDHEALTH GROUP INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 77,211,952 +348,891 0.42% $28,342,963,233 9 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Reduced 58,757,463 -554,062 0.45% $21,568,689,518 3 qtrs
STATE STREET CORPORATION Added 45,703,591 +70,324 0.49% $16,776,874,184 54 qtrs
FMR LLC Added 31,060,207 +3,067,212 0.49% $11,401,580,315 54 qtrs
Capital World Investors Reduced 28,480,541 -1,407,391 1.27% $10,455,486,517 54 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Added 24,577,840 +94,606 0.41% $9,022,033,507 3 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 22,173,963 -979,850 0.82% $8,139,620,000 54 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 20,745,390 -1,006,547 0.39% $7,580,119,656 54 qtrs
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Added 20,350,294 +519,706 0.96% $7,471,288,717 54 qtrs
JPMorgan Chase & Co Reduced 17,611,429 -2,634,618 0.36% $6,603,229,944 54 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 13, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
708,751
Shared
0
None
1,536

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.